CCM
ABBV icon

Carlson Capital Management’s AbbVie ABBV Stock Holding History

Carlson Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$361K Buy
2,029
+454
+29% +$83.5K 0.02% 86
2024
Q3 		$311K Buy
+1,575
New +$294K 0.01% 91
2024
Q1 		– Sell
-3,174
Closed -$492K – 104
2023
Q4 		$492K Buy
3,174
+1,127
+55% +$164K 0.03% 123
2023
Q3 		$305K Sell
2,047
-153
-7% -$22.5K 0.02% 132
2023
Q2 		$296K Buy
2,200
+117
+6% +$17.2K 0.02% 138
2023
Q1 		$332K Sell
2,083
-87
-4% -$13.3K 0.02% 124
2022
Q4 		$351K Sell
2,170
-389
-15% -$59.6K 0.03% 115
2022
Q3 		$343K Buy
2,559
+14
+0.6% +$2.01K 0.03% 108
2022
Q2 		$390K Sell
2,545
-177
-7% -$27K 0.03% 106
2022
Q1 		$441K Buy
2,722
+561
+26% +$81.5K 0.04% 106
2021
Q4 		$293K Buy
2,161
+21
+1% +$2.48K 0.03% 134
2021
Q3 		$231K Buy
2,140
+74
+4% +$8.46K 0.02% 150
2021
Q2 		$233K Buy
2,066
+39
+2% +$4.39K 0.03% 139
2021
Q1 		$219K Buy
+2,027
New +$217K 0.04% 136

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Carlson Capital Management's ABBV Position: Q4 2024 in Review

Carlson Capital Management increased its AbbVie (ABBV) stake by 29% in Q4 2024, buying an estimated $83.5K and bringing the position to 2,029 shares worth $361K. The position accounts for 0.02% of the portfolio, ranked #86.

Carlson Capital Management first reported a position in ABBV in Q1 2021 and has held it in 14 quarters since. The position peaked at $492K in Q4 2023. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Carlson Capital Management held 2,029 shares of AbbVie worth $361K as of Q4 2024.
  • Carlson Capital Management bought 454 AbbVie shares in Q4 2024, an estimated $83.5K.
  • AbbVie made up 0.02% of Carlson Capital Management's portfolio in Q4 2024, its #86 holding.
  • Carlson Capital Management first reported a position in AbbVie in Q1 2021 and has held it in 14 quarters since.
  • Carlson Capital Management's AbbVie position peaked at $492K in Q4 2023.
  • 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Carlson Capital Management's 13F filing for Q4 2024, filed 10 Feb 2025.